nach oben

Drugs

Erschienen in:

01.11.2009 | Review Article

The Role of the Laboratory in the Diagnosis of Invasive Candidiasis

verfasst von: Dr Maria Teresa Montagna, Giuseppina Caggiano, Elisa Borghi, Giulia Morace

Erschienen in: Drugs | Sonderheft 1/2009

Einloggen, um Zugang zu erhalten

Abstract

A diagnosis of invasive candidiasis can be achieved using conventional approaches (microscopy, culture, serology), as well as new methods, including antigen detection and polymerase chain reaction (PCR) assays. Most of the conventional approaches lack sensitivity, especially for obtaining a diagnosis of invasive candidiasis in immunocompromised patients. Antigen detection and PCR assays represent a valid alternative, in terms of their high potential sensitivity and specificity, but these procedures still need to be standardized and evaluated in a large number of patients.

Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9(4): 499–511PubMed

Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3: 230–40PubMedCrossRef

Calderone RA. Candida and candidiasis. Washington, DC: American Society for Microbiology Press, 2002

Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002; 40: 3551–7PubMedCrossRef

Malani PN, Bradley SF, Little RS, et al. Trends in species causing fungemia in a tertiary care medical centre over 12 years. Mycoses 2001; 44: 446–9PubMedCrossRef

Pfaller MA, Diekema DJ, Rinaldi MG, et al., and the Global Antifungal Surveillance Group. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005; 43: 5848–59PubMedCrossRef

Hajjeh RA, Sofair AN, Harrison IH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519–27PubMedCrossRef

Anaissie EJ, McGinnis MR, Pfaller MA. Clinical mycology. Philadelphia (PA): Churchill Livingstone, 2003

Dismukes WE, Sobel JD, Pappas PG. Clinical Mycology. Oxford: Oxford University Press, 2003

10.

Larone DH. Medically important fungi: a guide to identification. 4th ed. Washington, DC: American Society for Microbiology Press, 2002

11.

Bendinelli M, Chezzi C, Dettori G, et al. Micologia. In: Bendinelli M, Chezzi C, Dettori G, et al, editors. Microbiologia medica. Bologna: Monduzzi, 2005

12.

Sutton DA. Specimen collection, transport, and processing: mycology. In: Murray PR, editor. Manual of clinical microbiology. 9th ed. Washington, DC: American Society for Microbiology Press, 2007: 1728–36

13.

Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249–72PubMedCrossRef

14.

McGinnis MR. Laboratory handbook of medical mycology. New York: Academic Press, 1980

15.

Hazen KC, Howell SA. Candida, Cryptococcus and other yeasts of medical importance. In: Murray PR, editor. Manual of clinical microbiology. 9th ed. Washington, DC: American Society for Microbiology Press, 2007: 1762–88

16.

Shea YR. Algorithms for detection and identification of fungi. In: Murray PR, editor. Manual of clinical microbiology. 9th ed. Washington, DC: American Society for Microbiology Press, 2007: 1745–61

17.

De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46(12): 1813–21PubMedCrossRef

18.

Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1–3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654–9PubMedCrossRef

19.

Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006; 19: 165–256PubMedCrossRef

20.

Kavanagh K, editor. Medical mycology: cellular and molecular techniques. Chichester: John Wiley & Sons Ltd., 2006

21.

Spiess B, Sifarth W, Hummel M, et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007; 45: 3743–53PubMedCrossRef

22.

Wise MG, Healy M, Reece K, et al. Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR. J Med Microbiol 2007; 56: 778–87PubMedCrossRef

Titel: The Role of the Laboratory in the Diagnosis of Invasive Candidiasis
verfasst von: Dr Maria Teresa Montagna
Giuseppina Caggiano
Elisa Borghi
Giulia Morace
Publikationsdatum: 01.11.2009
Verlag: Springer International Publishing
Erschienen in: Drugs / Ausgabe Sonderheft 1/2009
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI: https://doi.org/10.2165/11315630-000000000-00000

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The Role of the Laboratory in the Diagnosis of Invasive Candidiasis

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2009

Clinical Aspects of Invasive Candidiasis in Critically Ill Patients

Pharmacological Properties of Antifungal Drugs with a Focus on Anidulafungin

Clinical Aspects of Invasive Candidiasis in the Surgical Patient

Candidaemia in Patients with an Inserted Medical Device

Conclusions

Invasive Fungal Infections